Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.

[1]  M. Felices,et al.  Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion , 2022, JCI insight.

[2]  D. Anglicheau,et al.  Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms , 2022, Frontiers in Immunology.

[3]  C. Macedo,et al.  Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection. , 2022, Trends in molecular medicine.

[4]  M. Naesens,et al.  Allorecognition and the spectrum of kidney transplant rejection. , 2021, Kidney international.

[5]  P. Van Vlierberghe,et al.  T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells , 2021, Frontiers in Immunology.

[6]  Dong Guo,et al.  Natural killer cells promote the differentiation of follicular helper T cells instead of inducing apoptosis in myasthenia gravis. , 2021, International immunopharmacology.

[7]  Harinder Singh,et al.  T-bet+CD27+CD21– B cells poised for plasma cell differentiation during antibody-mediated rejection of kidney transplants , 2021, JCI insight.

[8]  R. Gill,et al.  The natural killer cell activating receptor, NKG2D, is critical to antibody‐dependent chronic rejection in heart transplantation , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  J. Olivo-Marin,et al.  Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection. , 2020, Journal of the American Society of Nephrology : JASN.

[10]  D. Landsittel,et al.  Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation. , 2020, Journal of the American Society of Nephrology : JASN.

[11]  M. Stegall,et al.  The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  R. Colvin,et al.  Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B‐HOT) gene panel and open source multicenter validation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  G. Vidarsson,et al.  FcγR Binding and ADCC Activity of Human IgG Allotypes , 2020, Frontiers in Immunology.

[14]  W. Baldwin,et al.  Natural Killer Cells: Critical Effectors During Antibody-Mediated Rejection of Solid Organ Allografts. , 2020, Transplantation.

[15]  P. Nickerson,et al.  Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  R. Fulton,et al.  Harnessing Expressed Single Nucleotide Variation and Single Cell RNA Sequencing to Define Immune Cell Chimerism in the Rejecting Kidney Transplant , 2020, bioRxiv.

[17]  P. Bruneval,et al.  In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  R. Hendriks,et al.  The effects of an IL-21 receptor antagonist on the alloimmune response in a humanized mouse skin transplant model. , 2019, Transplantation.

[19]  P. Marquet,et al.  Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. , 2019, Kidney international.

[20]  D. Landsittel,et al.  Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant , 2018, Kidney international reports.

[21]  M. Tilanus,et al.  NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment , 2018, Front. Immunol..

[22]  P. Klenerman,et al.  CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells , 2018, Front. Immunol..

[23]  M. Parkes,et al.  Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection , 2017, Transplantation.

[24]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[25]  E. Reed,et al.  Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation , 2016, Front. Immunol..

[26]  A. Loundou,et al.  Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies , 2016, Front. Immunol..

[27]  U. Mouritzen,et al.  Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial. , 2016, International journal of clinical pharmacology and therapeutics.

[28]  Piet Demeester,et al.  FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[29]  J. Hernández,et al.  Circulating NK‐Cell Subsets in Renal Allograft Recipients With Anti‐HLA Donor‐Specific Antibodies , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[31]  W. Leonard,et al.  Interleukin-21: a double-edged sword with therapeutic potential , 2014, Nature Reviews Drug Discovery.

[32]  G. Comer,et al.  Anti‐IL21 receptor monoclonal antibody (ATR‐107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: A phase I, first‐in‐human study , 2014, Journal of clinical pharmacology.

[33]  F. Lehner,et al.  The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs , 2012, Front. Immunol..

[34]  A. Berrebi,et al.  CD160: a unique activating NK cell receptor. , 2011, Immunology letters.

[35]  V. Videm,et al.  Soluble ICAM‐1 and VCAM‐1 as Markers of Endothelial Activation , 2008, Scandinavian journal of immunology.

[36]  K. Skak,et al.  Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression , 2008, Immunology.

[37]  J. Bubier,et al.  Treatment of BXSB‐Yaa Mice with IL‐21R‐Fc Fusion Protein Minimally Attenuates Systemic Lupus Erythematosus , 2007, Annals of the New York Academy of Sciences.

[38]  B. Banas,et al.  Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  S. S. Chuang,et al.  The LLT1 receptor induces IFN-γ production by human natural killer cells , 2004 .

[40]  D. Foster,et al.  IL-21 Up-Regulates the Expression of Genes Associated with Innate Immunity and Th1 Response1 , 2002, The Journal of Immunology.

[41]  Hannah G Polikowsky,et al.  Supervised Machine Learning with CITRUS for Single Cell Biomarker Discovery. , 2019, Methods in molecular biology.

[42]  X. Jouven,et al.  IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. , 2016, Journal of the American Society of Nephrology : JASN.